Foundation Medicine Inc. said that Bill Gates of Microsoft fame is among investors who expanded the Cambridge company’s Series B financing round by an additional $13.5 million.

“Advances in understanding the human genome are having a dramatic impact on almost every area of medicine,” Gates said in a statement. “Foundation Medicine’s approach in harnessing the power of genomic data to improve care for cancer patients could represent an extremely important step forward in improving routine cancer care.”